|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.150 CNY | +0.11% |
|
+3.27% | -13.52% |
| Market Cap | 4.41B 654M 565M 527M 485M 914M 62.19B 926M 6.19B 2.43B 31.08B 2.46B 2.4B 103B | P/E 2024 |
-50.1x | P/E 2025 | 353x |
|---|---|---|---|---|---|
| Enterprise Value | 2.87B 425M 367M 342M 315M 594M 40.43B 602M 4.02B 1.58B 20.21B 1.6B 1.56B 67.02B | EV / Sales 2024 |
4.33x | EV / Sales 2025 | 8.78x |
| Free-Float |
42.82% | Yield 2024 * |
-
| Yield 2025 | 2.84% |
| 1 day | +0.11% | ||
| 1 week | +3.27% | ||
| Current month | +3.98% | ||
| 1 month | -8.13% | ||
| 3 months | -16.13% | ||
| 6 months | -17.34% | ||
| Current year | -13.52% |
| 1 week | 8.48 |  | 9.17 |
| 1 month | 8.35 | | 10.66 |
| Current year | 7.77 | | 12.9 |
| 1 year | 7.77 | | 16.25 |
| 3 years | 5.73 | | 17.49 |
| 5 years | 5.73 | | 18.75 |
| 10 years | 5.73 | | 28.08 |
| Manager | Title | Age | Since |
|---|---|---|---|
Biao Ma
CEO | Chief Executive Officer | 62 | 2001-07-04 |
Dong Na Liang
DFI | Director of Finance/CFO | 45 | 2024-01-25 |
Li Ma
DFI | Director of Finance/CFO | 57 | 2006-12-14 |
| Director | Title | Age | Since |
|---|---|---|---|
Xue Feng Wang
BRD | Director/Board Member | 48 | 2009-02-28 |
Biao Ma
CHM | Chairman | 62 | 2001-07-04 |
Li Ma
BRD | Director/Board Member | 57 | 2005-09-30 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.11% | +3.27% | -42.31% | -14.41% | 652M | |
| +4.86% | -4.16% | +52.13% | +160.26% | 995B | |
| +1.04% | -3.43% | +50.60% | +52.38% | 614B | |
| +0.98% | -6.46% | +24.85% | +66.66% | 431B | |
| +1.96% | -0.87% | +43.02% | +37.60% | 353B | |
| -0.11% | -4.56% | +31.59% | +39.73% | 293B | |
| +2.52% | -6.99% | +8.08% | +10.32% | 245B | |
| +4.57% | +3.75% | +35.07% | +67.64% | 210B | |
| -4.32% | -12.25% | -5.97% | -44.56% | 210B | |
| -2.58% | -1.91% | +15.06% | +67.46% | 168B | |
| Average | +0.42% | -3.78% | +21.21% | +44.31% | 351.89B | |
| Weighted average by Cap. | +0.66% | -5.89% | +36.57% | +75.02% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 416M 61.79M 53.37M 49.76M 45.79M 86.4M 5.88B 87.55M 585M 229M 2.94B 232M 227M 9.74B | 405M 60.05M 51.86M 48.36M 44.5M 83.96M 5.71B 85.08M 568M 223M 2.85B 226M 221M 9.47B |
| Net income | -68.85M -10.22M -8.82M -8.23M -7.57M -14.28M -972M -14.47M -96.68M -37.91M -486M -38.36M -37.52M -1.61B | 14.57M 2.16M 1.87M 1.74M 1.6M 3.02M 206M 3.06M 20.46M 8.02M 103M 8.12M 7.94M 341M |
| Net Debt | -1.57B -233M -201M -188M -173M -326M -22.18B -330M -2.21B -865M -11.08B -876M -856M -36.76B | -1.54B -229M -198M -184M -170M -320M -21.76B -324M -2.17B -849M -10.88B -859M -840M -36.07B |
Employees
489
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-05 | CN¥9.150 | +0.11% | 5,462,205 |
| 26-08-04 | CN¥9.140 | +2.70% | 7,066,002 |
| 26-08-03 | CN¥8.900 | +1.14% | 4,687,800 |
| 26-07-31 | CN¥8.800 | +3.29% | 6,649,600 |
| 26-07-30 | CN¥8.520 | -3.18% | 8,246,013 |
- Stock Market
- Stocks
- 300485 Stock
Select your edition
All financial news and data tailored to specific country editions
